NCT04616248 2026-01-07
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
Phase 1 Active not recruiting
University of Southern California
Institut de Cancérologie de Lorraine
Memorial Sloan Kettering Cancer Center
Bispebjerg Hospital
NYU Langone Health
Memorial Sloan Kettering Cancer Center
Bispebjerg Hospital